Lorillard — Debt Investor Presentation (April 2010)
25 slides from Lorillard's debt investor presentation, Apr 7, 2010
Slide 1: Senior Notes Offering April 2010
Senior Notes Offering April 2010 Lorillard, Inc. has filed a preliminary prospectus supplement and registration statement with the SEC relating to an offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement and registration statement on F
Slide 2: The Offering
The Offering Issuer: Lorillard Tobacco Company Guarantor: Lorillard, Inc. Security: Senior Unsecured Notes Offering: SEC Registered Size: Benchmark Ratings: Baa2 / BBB- (Stable / Negative) Use of Proceeds: General Corporate Purposes, which may include the repurchase, redemption or retirement of secu
Slide 3: Safe Harbor Disclaimer
Safe Harbor Disclaimer You are cautioned that certain statements made in this presentation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may project, indicate or im
Slide 4: Regulation G Compliance
Regulation G Compliance You are also reminded that during this presentation, certain non-GAAP financial measures, such as EBITDA may be discussed. These measures should not be considered an alternative to net income, or any other measure of financial performance or liquidity presented in accordance
Slide 5: Management Presenters
Management Presenters David Taylor Executive Vice President, Finance and Planning and Chief Financial Officer
Slide 6: Agenda
Agenda Overview FDA Litigation Historical Financial Performance
Slide 7: Lorillard Overview
Lorillard Overview Third largest tobacco company in the United States Sell products only in the U.S., Puerto Rico and U.S. possessions Spun off from Loews Corporation in June 2008 Leading position in the two best performing categories in the cigarette market Strong brand portfolio led by the Newport
Slide 8: Trends in the U.S. Cigarette Market
Trends in the U.S. Cigarette Market Industry unit volume has declined at a 3.9% CAGR over the past seven years and declined 8.6% in 2009 Increases in federal and state excise taxes impacted recent trends Longer term trends unclear (billions of cigarettes shipped) 2002 - 2009 CAGR (3.9%) Source: Dome
Slide 9: Strong Brand Portfolio is Led by Newport
Strong Brand Portfolio is Led by Newport Source: Lorillard Shipment Data. Includes Old Gold, Maverick, Kent, True and Max brands. Accounted for 88.9% of domestic shipments in 2009 Newport (91.5% of sales) Primary driver of profitability Kent, True and Max Mature brands -- harvesting profit Premium B
Slide 10: Operating Strategy
Operating Strategy Continue to manage business with long-term perspective Continued focus on premium price segment via Newport Manage Maverick's growth in discount price segment to optimize brand profitability Harvest profits from all other brands Balance trade-off between Newport's market share gro
Slide 11: Menthol Continues to Gain Share
Menthol Continues to Gain Share As consumer preferences continue to evolve, Lorillard is best positioned to capitalize on that trend Source: Domestic wholesale shipments per MSAI (adjusted to exclude Camel Crush). 26.4% 26.7% 27.4% 27.9% 28.4% 28.8% 20.0% 21.0% 22.0% 23.0% 24.0% 25.0% 26.0% 27.0% 28
Slide 12: Newport Leads the Menthol Segment
Newport Leads the Menthol Segment 2004 2005 2006 2007 2008 2009 Newport 0.301 0.315 0.322 0.329 0.34 0.341 Marlboro Menthol 0.128 0.142 0.15 0.164 0.177 0.189 Kool 0.112 0.115 0.114 0.111 0.101 0.083 Salem 0.085 0.075 0.068 0.064 0.06 0.056 Camel Menthol 0.011 0.01 0.023 0.029 0.028 0.023 w/o blend
Slide 13: Family Smoking Prevention and Tobacco Control Act
Family Smoking Prevention and Tobacco Control Act Signed into law on June 22, 2009
Slide 14: FDA Authority Key Dates
FDA Authority Key Dates - General Obligations Publish 1996 Marketing and Sales Rule as Final Establish Center for Tobacco Products Establish 12-member Tobacco Products Scientific Advisory Committee FDA Obligation: To be effective June 22, 2010 Established 9 voting members and 3 non-voting members na
Slide 15: Scientific Advisory Committee
Scientific Advisory Committee Consider all matters related to tobacco - not just menthol Consideration of menthol cigarettes is first order of business Timing of recommendation to FDA Expected by March 2011 Due dates are frequently missed and postponed
Slide 16: Litigation
Leollliad Litigation
Slide 17: Major Types of Litigation
Class Actions/Mass Tort Cases Personal Injury/Reimbursement of Medical Expenses "Lights" (Low Tar) Individual Smoking and Health cases Standard individual cases W. Virginia consolidated individual case Broin flight attendant cases Engle "progeny" cases Kent Filter cases (Lorillard only) DOJ case: un
Slide 18: Financial Results
Leollliad Financial Results
Slide 19: Financial Policy Highlights
Financial Policy Highlights Uses for free cash flow Capital investment (~$50 million per year) Dividends (target payout ratio of 70 - 75% of earnings) Share repurchases - 3 programs completed since spin-off totaling $1.4 billion Potential acquisitions Capital structure Successfully completed first d
Slide 20: Summary Historical Income Statement
Summary Historical Income Statement Stable top-line and earnings profile
Slide 21: Summary Historical Balance Sheet
Summary Historical Balance Sheet
Slide 22: Summary Historical Cash Flow Statement
Summary Historical Cash Flow Statement Lorillard has a history of generating strong and sustainable cash flow
Slide 23: Highlights
Highlights Leader in the best performing segments of the cigarette market Significant Newport brand equity and customer loyalty Efficient business model and disciplined operating philosophy focused on optimizing profitability Track record of strong, stable and consistent cash flow generation Well-po
Slide 24: Appendix A Regulation G Reconciliations
Appendix A Regulation G Reconciliations Reconciliation of Net Income to EBITDA ($ in millions) 2007 2008 2009 Net Income $ 898 $ 887 $ 948 Add: Income Taxes 485 547 571 Other (Income) Expense, net Other (Income) Expense, net (109) (19) 22 Operating Income $ 1,274 $ 1,415 $ 1,541 Depreciation & Amort
Slide 25: Thank You
Leollliad Thank You